research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Synthesis, crystal structure, Hirshfeld surface analysis, MEP study and mol­ecular docking of N-{3-[(4-meth­­oxy­phen­yl)carbamo­yl]phen­yl}-3-nitro­benzamide as a promising inhibitor of hfXa

CROSSMARK_Color_square_no_text.svg

aGrupo de Cristalografía, Departamento de Química, Universidad del Valle, A.A 25360 Santiago de Cali, Colombia, and bWestCHEM. Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1XL, Scotland
*Correspondence e-mail: rodolfo.moreno@correounivalle.edu.co

Edited by G. Diaz de Delgado, Universidad de Los Andes, Venezuela (Received 22 July 2020; accepted 13 October 2020; online 20 October 2020)

The title compound, C21H17N3O5, consists of three rings, A, B and C, linked by amide bonds with the benzene rings A and C being inclined to the mean plane of the central benzene ring B by 2.99 (18) and 4.57 (18)°, respectively. In the crystal, mol­ecules are linked via N—H⋯O and C—H⋯O hydrogen bonds, forming fused R22(18), R34(30), R44(38) rings running along [[\overline{1}]0[\overline{1}]] and R33(37) and R33(15) rings along [001]. Hirshfeld analysis was undertaken to study the inter­molecular contacts in the crystal, showing that the most significant contacts are H⋯O/O⋯H (30.5%), H⋯C/C⋯H (28.2%) and H⋯H (29.0%). Two zones with positive (50.98 and 42.92 kcal mol−1) potentials and two zones with negative (−42.22 and −34.63 kcal mol−1) potentials promote the N—H⋯O inter­actions in the crystal. An evaluation of the mol­ecular coupling of the title compound and the protein with enzymatic properties known as human coagulation factor Xa (hfXa) showed the potential for coupling in three arrangements with a similar minimum binding energy, which differs by approximately 3 kcal mol−1 from the value for the mol­ecule Apixaban, which was used as a positive control inhibitor. This suggests the title compound exhibits inhibitory activity.

1. Chemical context

The synthesis of new compounds derived from amino­benzamides has generated a growing inter­est in the search for mol­ecular systems that can have different physical, chemical or biological properties. Some amino­benzamide derivatives present high efficiencies in their non-linear optical properties (Prasad et al., 2011[Prasad, L. G., Krishnakumar, V., Nagalakshmi, R. & Manohar, S. (2011). Mater. Chem. Phys. 128, 90-95.]). Exceptional insecticidal activity against lepidopterous insects has been shown by some anthranilic di­amides (Lahm et al., 2005[Lahm, G. P., Selby, T. P., Freudenberger, J. H., Stevenson, T. M., Myers, B. J., Seburyamo, G., Smith, B. K., Flexner, L., Clark, C. E. & Cordova, C. (2005). Bioorg. Med. Chem. Lett. 15, 4898-4906.]) and benzene dicarboxamide derivatives (Tohnishi et al., 2005[Tohnishi, M., Nakao, H., Furuya, T., Seo, A., Kodama, H., Tsubata, K., Fujioka, S., Kodama, H., Hirooka, T. & Nishimatsu, T. (2005). J. Pestic. Sci. 30, 354-360.]; Lahm et al., 2007[Lahm, G. P., Stevenson, T. M., Selby, T. P., Freudenberger, J. H., Cordova, D., Flexner, L., Bellin, C. A., Dubas, C. M., Smith, B. K., Hughes, K. A., Hollingshaus, J. G., Clark, C. E. & Benner, E. A. (2007). Bioorg. Med. Chem. Lett. 17, 6274-6279.]). Other substituted benzamides are used as medications for patients with schizophrenia (Racagni et al., 2004[Racagni, G., Canonico, P. L., Ravizza, L., Pani, L. & AMoRe, M. (2004). Neuropsychobiology, 50, 134-143.]). Some benzamide compounds are used in the area of neurology for their powerful neuroprotective effects (Hirata et al., 2018[Hirata, Y., Sasaki, T., Kanki, H., Choong, C.-J., Nishiyama, K., Kubo, G., Hotei, A., Taniguchi, M. & Mochizuki, H. (2018). Sci. Rep. 8, 1400, 1-9.]). Other di­amide compounds analogous to the product obtained in this work have been tested as potential options for anti­thrombotic treatments by acting as direct inhibitors of coagulation factor Xa (Xing et al., 2018[Xing, J., Yang, L., Zhou, J. & Zhang, H. (2018). Bioorg. Med. Chem. 26, 5987-5999.]; Lee et al., 2017[Lee, S., Lee, W., Nguyen, T., Um, I., Bae, J. & Ma, E. (2017). Int. J. Mol. Sci. 18, 1144-1170.]). This study was undertaken with the aim of providing new compounds with possible pharmaceutical applications. The results of the synthesis, crystal-structure determination by single-crystal X-ray diffraction, supra­molecular analysis and an evaluation of mol­ecular coupling on human factor Xa of the title compound, (I)[link], a new di­amide derived from 3-amino­benzamide, is presented here.

[Scheme 1]

2. Structural commentary

In the title compound, Fig. 1[link], the mean planes of rings A (C1–C6; r.m.s deviation = 0.0127 Å) and C (C15–C20; r.m.s deviation = 0.0086 Å) form dihedral angles of of 2.99 (18) and 4.57 (18)°, respectively, with the mean plane of the central ring B (C8–C13; r.m.s deviation = 0.0072 Å). In turn, the amide groups C8/N2/C7(O3)/C1 (r.m.s deviation = 0.0081 Å) and C15/N3/C14(O4)/C10 (r.m.s deviation = 0.0101 Å), which link the rings, are inclined by 37.72 (15) and 29.35 (16)°, respectively, to ring B. The nitro group forms an angle of 5.3 (2)° with ring A while the meth­oxy group is approximately coplanar with ring C, forming an angle of 1.1 (5)°. The mol­ecule is formed by three main planes resulting from the planes that form the rings with the B ring resembling a fallen step between A and C. All bond lengths (Allen et al., 1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-S19.]) and bond angles are within normal ranges.

[Figure 1]
Figure 1
The mol­ecular structure of (I)[link], showing the atom labeling and displacement ellipsoids drawn at the 50% probability level.

3. Supra­molecular features

The crystalline packing in compound (I)[link] is mainly regulated by the presence of N—H⋯O and C—H⋯O hydrogen bonds. The N2—H2N⋯O4i and N3—H3N⋯O3ii inter­actions [symmetry codes: (i) −x + 1, y + [{1\over 2}], −z + 1; (ii) −x, y + [{1\over 2}], −z + 1] form fused R22(18), R43(30) and R44(38) rings (Etter, 1990[Etter, M. C. (1990). Acc. Chem. Res. 23, 120-126.]) running along [[\overline{1}]0[\overline{1}]] (see Table 1[link] and Fig. 2[link]a). In turn, playing the role of complementary inter­actions in crystal growth, other C—H⋯O-type inter­actions [C19—H19⋯O1iv and C21—H21C⋯O1v; symmetry codes: (iv) x − 1, y, z + 1; (v) −x + 1, y − [{1\over 2}], −z + 1] link the mol­ecules at their ends, ensuring their stability in the growth process. Together with the N—H⋯O inter­actions, they contribute to the formation of additional fused R33(37) and R33(15) rings, which run along [001] (see Table 1[link], Fig. 2[link]b). Weak C21—H21BCg1 inter­actions occur, where Cg1 is the centroid of the C1–C6 benzene ring, with a H21BCg1 distance of 2.83 Å.

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
N2—H2N⋯O4i 0.88 2.09 2.908 (4) 155
N3—H3N⋯O3ii 0.88 2.21 3.056 (4) 163
C5—H5⋯O2iii 0.95 2.28 3.093 (5) 143
C19—H19⋯O1iv 0.95 2.44 3.365 (5) 164
C21—H21C⋯O1v 0.98 2.64 3.490 (5) 145
Symmetry codes: (i) [-x+1, y+{\script{1\over 2}}, -z+1]; (ii) [-x, y+{\script{1\over 2}}, -z+1]; (iii) x, y-1, z; (iv) x-1, y, z+1; (v) [-x+1, y-{\script{1\over 2}}, -z+1].
[Figure 2]
Figure 2
(a) Partial crystal structure of (I)[link], showing the formation of D = R22(18), E = R43(30) and F = R44(38) fused rings running along [[\overline{1}]0[\overline{1}]] and (b) G = R33(37) and H = R33(15) fused rings. These fused rings run along [001]. Symmetry code: (vi) x − 1, y − 1, z + 1.

4. Hirshfeld surface analysis

Inter­molecular inter­actions, including hydrogen-bond inter­actions, are essential in reinforcing the stability of the supra­molecular structure. This behavior can be analyzed through the study of Hirshfeld surfaces (HS) using the CrystalExplorer program (Spackman & Jayatilaka, 2009[Spackman, M. A. & Jayatilaka, D. (2009). CrystEngComm, 11, 19-32.]), which allows the visualization of the inter­actions within the crystal structure, including N⋯H and C⋯H inter­actions. To examine in depth the strength and capacity of hydrogen bonds and other inter­molecular contacts, one of the Hirshfeld surface analysis tools, the normalized contact distance, dnorm, has been used (Turner et al., 2017[Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Spackman, P. R., Jayatilaka, D. & Spackman, M. A. (2017). CrystalExplorer17. The University of Western Australia. https://https://crystalexplorer. scb. uwa. edu. au/.]). The results show that the most important contributions to the crystal packing are due to the N—H⋯O and C—H⋯O hydrogen bonds. This is evidenced by the more intense red spots on the HS for (I)[link] (see Fig. 3[link]a,b). The overall two-dimensional fingerprint plot (Fig. 4[link]a), and those delineated into by H⋯O/O⋯H, H⋯H, H⋯C/C⋯H, C⋯C, N⋯C/C⋯N, H⋯N/N⋯H, O⋯O, O⋯C/C⋯O, and N⋯O/O⋯N contacts are illustrated in Fig. 4[link]bj, respectively, together with their relative contributions to the Hirshfeld surface. The most important inter­action corresponds to H⋯O/O⋯H contributing 30.5% to the overall crystal packing, as shown in Fig. 4[link]b. The pair of spikes in the fingerprint plot have a symmetrical distribution of high-density points with the tip at de + di = 1.98 Å. The H⋯H inter­actions, shown in Fig. 4[link]c, contribute 29.0% to the total crystal packing and appear as widely dispersed points of high density due to the large hydrogen-atom content of the mol­ecule with the rounded tip at de + di = 1.20 Å. The presence of C—H⋯π inter­actions is shown as a pair of characteristic wings on the fingerprint plot (Fig. 4[link]d), delineated into H⋯C/C⋯H contacts (28.2% contribution to the HS) having the tip at de + di = 2.84 Å. These results reveal the importance of H-atom contacts in establishing the packing. The large number of H⋯H, H⋯C/C⋯H and H⋯O/O⋯H inter­actions suggest that van der Waals inter­actions and hydrogen bonding play major roles in the crystal packing (Hathwar et al., 2015[Hathwar, V. R., Sist, M., Jørgensen, M. R. V., Mamakhel, A. H., Wang, X., Hoffmann, C. M., Sugimoto, K., Overgaard, J. & Iversen, B. B. (2015). IUCrJ, 2, 563-574.]).

[Figure 3]
Figure 3
(a) A view of the Hirshfeld surface of (I)[link] mapped over dnorm emphasizing the N—H⋯O and C—H⋯O inter­molecular inter­actions and (b) showing the H⋯O/O⋯H and C⋯C (ππ) inter­actions. Symmetry codes: (i) −x + 1, y + [{1\over 2}], −z + 1; (ii) −x, y + [{1\over 2}], −z + 1; (iii) x − 1, y, z + 1.
[Figure 4]
Figure 4
Two-dimensional fingerprints plots for the title compound, showing (a) all inter­actions, (b) H⋯O/O⋯H, (c) H⋯H, (d) H⋯C/C⋯H, (e) C⋯C, (f) N⋯C/C⋯N, (g) H⋯N/N⋯H, (h) O⋯O, (i) O⋯C/C⋯O, and (j) N⋯O/O⋯N inter­actions. The di and de values are the closest inter­nal and external distances (in Å) of given points on the Hirshfeld surface.

5. Mol­ecular Electrostatic Potential (MEP)

A study of the mol­ecular electrostatic potential (MEP) of (I)[link] using the Gauss09W (Frisch et al., 2009[Frisch, M. J., et al. (2009). GAUSSIAN09. Gaussian Inc., Wallingford, CT, USA.]) and Gauss View 5.0 programs, at the DFT/B3LYP/6-31G (d, p) level of theory, to obtain a qualitative analysis and the Multiwfn 3.6 program for a qu­anti­tative analysis (Lu & Chen, 2012[Lu, T. & Chen, F. (2012). J. Mol. Graphics Modell. 38, 314-323.]) of the surface was undertaken. On the potential surface, marked in dark blue, positive regions of low electron density that can suffer nucleophilic attacks in a chemical reaction or can have inter­actions with nucleophiles in the process of crystalline growth are shown (see Fig. 5[link]). Two zones show positive potentials of 50.98 and 42.92 kcal mol−1 in regions that follow the directions of the N—H bonds above and below the plane through the rings of the mol­ecule and which promote the formation of the N2—H2N⋯O4i and N3—H3N⋯O3ii hydrogen bonds throughout the crystal. In turn, other areas with high density, being close to the carbonyl oxygen atoms and shown in a reddish color, show values of −42.22 and −34.63 kcal mol−1. Thus, in the first stage of crystal formation, these low and high electronic density regions are inter­twined to promote the formation of rings and chains of mol­ecules along the crystal. The other areas with lower values in the regions will be accommodated to enable the formation of other weaker bonds, C5—H5⋯O2iii, C19—H19⋯1iv and C21—H21C⋯O1v, representing the growth characteristics of each crystal.

[Figure 5]
Figure 5
Three-dimensional representation of the electrostatic potential around a mol­ecule of (I)[link].

6. Mol­ecular Docking Evaluation

One of the newest synthetic direct-acting compounds to be licensed for the treatment of therapeutic anti­coagulation is Apixaban. To evaluate its potential as an anti­coagulant agent, a mol­ecular docking study of (I)[link] as a ligand and the human coagulation factor hfXa as the receptor protein was performed. For the mol­ecular coupling calculations, the free software Autodock Vina 4.2.6 (Trott & Olson, 2010[Trott, O. & Olson, A. (2010). J. Comput. Chem. 31, 455-461.]) was used, and as a positive control ligand in the active site, the mol­ecule Apixaban (PDB code 2p16; Pinto et al., 2007[Pinto, D., Orwat, M., Koch, S., Rossi, K., Alexander, R., Smallwood, A., Wong, P., Rendina, A., Luettgen, J., Knabb, R., He, K., Xin, B., Wexler, R. R. & Lam, P. Y. S. (2007). J. Med. Chem. 50, 5339-5356.]), one of the most important substrates currently accepted by the US Food and Drug Administration (FDA) for anti­thrombotic treatments (Agnelli et al., 2013[Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E. & Weitz, J. I. (2013). N. Engl. J. Med. 368, 699-708.]) was used. The Apixaban mol­ecule was also used as a model for the validation and verification of the parameters of the mol­ecular coupling calculations performed. The bonding energy obtained for the new inhibitor was −7.7 and −10.7 kcal mol−1 for the control ligand (Table 2[link]). Compound (I)[link], as a ligand at the active site of hfXa, presents one hydrogen bond of medium strength between the local N2 atom and the amino acid residue Gly218. However, all hydro­phobic residue contacts of the latter in its more stable configuration are also present in the positive control ligand with the exception of Glu217. The results of the mol­ecular coupling calculations show that ligand (I)[link] has two equivalent energy configurations, poses 2 and 3 (see Table 3[link]), which differ energetically from pose 1 by only 0.1 and 0.3 kcal mol−1, respectively. Thus, pose 3 presents a better 3D conformational arrangement at the active site, this pose being much more similar to that of the control ligand (see Fig. 6[link]). This behavior implies that two of the three hydrogen bonds presented by the control ligand in the active site Gly216 and Gln192, plus all hydro­phobic contacts of ligand (I)[link] in its pose 3, coincide with those presented by the control ligand. For this reason, the difference in binding energy between (I)[link] and the control ligand at the active site is due to the chemical difference between the functional groups present in each structure. The mol­ecular coupling images were generated using the programs PyMOL (Rigsby & Parker, 2016[Rigsby, R. & Parker, A. (2016). Biochem. Mol. Biol. Educ. 44, 433-437.]) and Ligplot+ (Laskowski & Swindells, 2011[Laskowski, R. & Swindells, M. (2011). J. Chem. Inf. Model. 51, 2778-2786.]).

Table 2
Mol­ecular coupling calculations (kcal mol−1) for the active hfXa site, the title compound, and the Apixaban mol­ecule

Compound Bond energya No. of hydrogen bondsb Hydrogen-bonding inter­action residuesb van der Waals inter­action residuesb
(I) −7.7 1 Gly218 Trp215, Cys191, Ser195, Gln192, Cys220, Gly218, Ala190, Gly216, Gly 226, Asp189, Val213, Phe174, Glu217, Glu 146
Apixabanc −10.7 3 Gly216, Gln192, Glu146 Cys220, Tyr99, Glu97, Phe174, Thr98, Val213, Trp215, Gly226, Cys191, Asp189, Ser195, Ile227, Ala190, Gly218, Arg143
Notes: (a) The binding energy indicates the affinity and binding capacity for the active site of the enzyme protein fXa; (b) The number of hydrogen bonds and all amino acid residues involved in the enzyme-inhibitor complex were determined using AutoDock 4.2.6 (Trott & Olson, 2010[Trott, O. & Olson, A. (2010). J. Comput. Chem. 31, 455-461.]); (c) The Apixaban mol­ecule was used as a positive control ligand for the active site.

Table 3
Equivalent poses of compound (I)[link] in the active hfXa site, as a result of mol­ecular coupling calculations (kcal mol−1)

Compound Bond energya No. of hydrogen bondsb Hydrogen-bonding inter­action residuesb van der Waals inter­action residuesb
(I) (pose 1) −7.7 1 Gly218 Trp215, Cys191, Ser195, Gln192, Cys220, Gly218, Ala190, Gly216, Gly 226, Asp189, Val213, Phe174, Glu217, Glu 146
(I) (pose 2) −7.6 1 Gly192 Phe174, Tyr99, Val213, Gly226, Trp215, Ser195, Asp189, Ala190, Gly218, Gly216, Cys191, Gln192, Ile 227, Lys96
(I) (pose 3) −7.4 2 Gly 216, Gln192 Cys220, Glu217, Phe174, Val213, Gly226, Cys191, Ser195, Ala190, Trp215, Gly218, Ile227
Notes: (a) The binding energy indicates the affinity and binding capacity for the active site of the enzyme protein fXa; (b) The number of hydrogen bonds and all amino acid residues involved in the enzyme-inhibitor complex were determined using AutoDock 4.2.6 (Trott & Olson, 2010[Trott, O. & Olson, A. (2010). J. Comput. Chem. 31, 455-461.]); (c) The Apixaban mol­ecule was used as a positive control ligand for the active site.
[Figure 6]
Figure 6
Models of mol­ecular coupling for inhibition of hfXa by compound (I)[link] in its poses: (a) and (d) pose 1; (b) and (e) pose 2, and (c) and (f) pose 3. Dashed lines indicate hydrogen bonds. Carbon atoms are in black, nitro­gen in blue and oxygen in red.

7. Database survey

A search of the Cambridge Structural Database (CSD, version 5.41, November 2019 update; Groom et al., 2016[Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171-179.]) using [3-(benzoyl-λ2-azan­yl)phen­yl](phenyl-λ2-azan­yl)methanone as the main skeleton gave 76 hits. Seven structures containing the [3-(benzoyl-λ2-azan­yl)phen­yl](phenyl-λ2-azan­yl)methanone framework with nitro and meth­oxy groups as substituents similar to the title compound were found, viz., N-{3-[N′-(2-meth­oxy­phen­yl)carbamo­yl]-5-methyl-2-meth­oxy­phen­yl}-2-meth­oxy-5-methyl-3-nitro­benzamide (HEXXOY; Yi et al., 2007[Yi, H.-P., Wu, J., Ding, K.-L., Jiang, X.-K. & Li, Z.-T. (2007). J. Org. Chem. 72, 870-877.]), N-{3-[N′-(2-meth­oxy­phen­yl)carbamo­yl]-5-methyl-2-meth­oxy­phen­yl}-2-hy­droxy-5-methyl-3-nitro­benzamide (HEXYAL; Yi et al., 2007[Yi, H.-P., Wu, J., Ding, K.-L., Jiang, X.-K. & Li, Z.-T. (2007). J. Org. Chem. 72, 870-877.]), methyl 3-({2-hy­droxy-3-[(2-meth­oxy­benzo­yl)amino]­benzo­yl}amino)-2-meth­oxy­benzoate (POQMEP; Liu et al., 2014[Liu, J., Sun, C., Ma, W., Lu, Y.-J., Yu, L., Zhang, K. & Zeng, H. (2014). RSC Adv. 4, 54469-54473.]), catena-[[μ-methyl 3-({2-oxy-3-[(2-meth­oxy-3-nitro­benzo­yl)amino]­benzo­yl}amino)-2-meth­oxy­benzoate]aqua­sodium methanol solvate] (POQMIT; Liu et al., 2014[Liu, J., Sun, C., Ma, W., Lu, Y.-J., Yu, L., Zhang, K. & Zeng, H. (2014). RSC Adv. 4, 54469-54473.]), methyl 2-meth­oxy-3-({2-meth­oxy-3-[(2-meth­oxy-3-nitro­benzo­yl)amino]­benzo­yl}amino)­benzoate (YUXMIO; Yan et al., 2010[Yan, Y., Qin, B., Ren, C., Chen, X., Yip, Y. K., Ye, R., Zhang, D., Su, H. & Zeng, H. (2010). J. Am. Chem. Soc. 132, 5869-5879.]), methyl 3-({3-[(2,5-dimeth­oxy-3-nitro­benzo­yl)amino]-2-meth­oxy­benzo­yl}amino)-2,5-di­meth­oxy­benzoate (YUXNEL; Yan et al., 2010[Yan, Y., Qin, B., Ren, C., Chen, X., Yip, Y. K., Ye, R., Zhang, D., Su, H. & Zeng, H. (2010). J. Am. Chem. Soc. 132, 5869-5879.]), and methyl 3-({3-[(2,5-dimeth­oxy-3-nitro­benzo­yl)amino]-2,5-di­meth­oxy­benzo­yl}amino)-2,5-di­meth­oxy­benzoate (YUXNOV; Yan et al., 2010[Yan, Y., Qin, B., Ren, C., Chen, X., Yip, Y. K., Ye, R., Zhang, D., Su, H. & Zeng, H. (2010). J. Am. Chem. Soc. 132, 5869-5879.]). The specific characteristics of these di­amide systems depend on the presence of the diverse substituents and their position in the rings in such a way that the planarity in the system is maintained between two rings and the third ring is rotated with respect to the first two. In this way, the compounds POQMEP, POQMIT and HEXXOY present a relatively small deviation from planarity, while the systems YUXNOV, YUXNEL, HEXYAL, YUXMIO progressively lose this planarity, ending up with quite large dihedral angles between the planes.

8. Synthesis and crystallization

3-Amino-N-(4-meth­oxy­phen­yl)benzamide (ii) (50.5 mg, 0.129 mmol), previously synthesized, was subjected to an acyl­ation reaction in 3-nitro­benzoyl chloride (a) (50.5 mg, 0.272 mmol) under chloro­form reflux conditions to obtain compound (I)[link] [yield 44.7 mg (0.114 mmol), 88.4%; m.p. 502 (1) K].

[Scheme 2]

FT–IR (ATR): υ (cm−1) = 3338, 3285 (N—H), 3076, 2969, 1650, 1637 (C=O), 1585 (C=C), 1526, 1510, 1434, 1353 (NO2), 1316, 1301, 1241, 1137, 1026, 898, 829, 819, 721, 683 cm−1. The UV–Vis spectrum for (I)[link] (60 µM) was obtained in DMF with a maximum of 273 nm (0.62 absorption). MS (IE, 40 eV), m/z [M+] calculated for C21H17N3O5+: 391.12 (100%) and 392.12 (23.1%); found: 391.10 and 392.10 (25.1%).

9. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 4[link]. All the H atoms were found in a difference-Fourier map and were positioned at geometrically idealized positions, C—H = 0.95 Å (ring), N—H = 0.88 Å and C—H = 0.98 Å (meth­yl) and were refined using a riding-model approximation, with Uiso(H) = 1.2Ueq(parent atom) or 1.5Ueq(C). After refinement, ROTAX suggested twinning by a 180° about [100]. This law was used to generate an hklf5 format reflection file. Refinement against this file improved R factors and residual Q peaks·BASF refined to 0.090 (4)

Table 4
Experimental details

Crystal data
Chemical formula C21H17N3O5
Mr 391.37
Crystal system, space group Monoclinic, P21
Temperature (K) 123
a, b, c (Å) 7.2948 (3), 7.1242 (3), 16.8297 (7)
β (°) 97.644 (3)
V3) 866.86 (6)
Z 2
Radiation type Cu Kα
μ (mm−1) 0.91
Crystal size (mm) 0.50 × 0.40 × 0.18
 
Data collection
Diffractometer Oxford Diffraction Gemini S
Absorption correction Multi-scan
Tmin, Tmax 0.603, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections 3172, 3172, 2982
Rint 0.048
(sin θ/λ)max−1) 0.620
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.047, 0.126, 1.06
No. of reflections 3172
No. of parameters 263
No. of restraints 3
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.23, −0.30
Absolute structure Flack x determined using 524 quotients [(I+)−(I)]/[(I+)+(I)] (Parsons et al., 2013[Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249-259.])
Absolute structure parameter 0.2 (3)
Computer programs: CrysAlis PRO (Agilent, 2014[Agilent (2014). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.]), SIR92 (Altomare et al., 1994[Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C., Polidori, G. & Camalli, M. (1994). J. Appl. Cryst. 27, 435.]), SHELXL2014/7 (Sheldrick, 2015[Sheldrick, G. M. (2015). Acta Cryst. C71, 3-8.]), Mercury (Macrae et al., 2020[Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst. 53, 226-235.]) and ORTEP-3 for Windows (Farrugia, 2012[Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.]).

Supporting information


Computing details top

Data collection: CrysAlis PRO (Agilent, 2014); cell refinement: CrysAlis PRO (Agilent, 2014); data reduction: CrysAlis PRO (Agilent, 2014); program(s) used to solve structure: SIR92 (Altomare et al., 1994); program(s) used to refine structure: SHELXL2014/7 (Sheldrick, 2015); molecular graphics: Mercury (Macrae et al., 2020); software used to prepare material for publication: ORTEP-3 for Windows (Farrugia, 2012).

N-{3-[(4-Methoxyphenyl)carbamoyl]phenyl}-3-nitrobenzamide top
Crystal data top
C21H17N3O5Dx = 1.499 Mg m3
Mr = 391.37Melting point: 502(1) K
Monoclinic, P21Cu Kα radiation, λ = 1.54184 Å
a = 7.2948 (3) ÅCell parameters from 3172 reflections
b = 7.1242 (3) Åθ = 5.3–73.1°
c = 16.8297 (7) ŵ = 0.91 mm1
β = 97.644 (3)°T = 123 K
V = 866.86 (6) Å3Fragment cut from large slab, pale yellow
Z = 20.50 × 0.40 × 0.18 mm
F(000) = 408
Data collection top
Oxford Diffraction Gemini S
diffractometer
2982 reflections with I > 2σ(I)
Radiation source: sealed tubeRint = 0.048
ω scansθmax = 73.1°, θmin = 5.3°
Absorption correction: multi-scanh = 86
Tmin = 0.603, Tmax = 1.000k = 88
3172 measured reflectionsl = 2020
3172 independent reflections
Refinement top
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.047 w = 1/[σ2(Fo2) + (0.066P)2 + 0.3205P]
where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.126(Δ/σ)max < 0.001
S = 1.06Δρmax = 0.23 e Å3
3172 reflectionsΔρmin = 0.30 e Å3
263 parametersAbsolute structure: Flack x determined using 524 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
3 restraintsAbsolute structure parameter: 0.2 (3)
Special details top

Experimental. CrysAlisPro, Agilent Technologies, Version 1.171.37.35 (release 13-08-2014 CrysAlis171 .NET) (compiled Aug 13 2014,18:06:01) Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. Refined as a two-component twin

After refinement ROTAX suggested twinning by a 180 rotation about direct 1 0 0.

This law was used to generate a hklf5 formated reflection file.

Refinement against this file improved R factors and residual Q peaks.

BASF refined to 0.090 (4)

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
O10.6697 (5)0.7564 (5)0.02367 (18)0.0376 (8)
O20.5804 (5)0.9765 (5)0.09701 (19)0.0350 (7)
O30.2455 (4)0.5231 (5)0.35551 (16)0.0282 (6)
O40.2775 (4)0.5306 (4)0.64175 (16)0.0263 (6)
O50.1675 (4)0.3265 (4)0.93736 (17)0.0277 (7)
N10.6116 (4)0.8119 (5)0.0852 (2)0.0246 (7)
N20.3987 (4)0.8014 (5)0.37262 (18)0.0197 (7)
H2N0.47920.87440.35310.024*
N30.0451 (4)0.7137 (5)0.67641 (19)0.0198 (7)
H3N0.01810.81740.66460.024*
C10.4599 (5)0.5945 (6)0.2656 (2)0.0200 (8)
C20.5006 (5)0.7309 (6)0.2117 (2)0.0201 (7)
H20.47570.85980.21990.024*
C30.5793 (5)0.6713 (6)0.1453 (2)0.0214 (8)
C40.6237 (5)0.4862 (7)0.1322 (2)0.0249 (8)
H40.67750.45100.08600.030*
C50.5880 (5)0.3544 (6)0.1879 (2)0.0263 (9)
H50.62200.22710.18170.032*
C60.5021 (5)0.4077 (6)0.2532 (2)0.0223 (8)
H60.47180.31500.28990.027*
C70.3569 (5)0.6363 (6)0.3358 (2)0.0212 (8)
C80.3212 (5)0.8658 (6)0.4411 (2)0.0187 (8)
C90.2817 (5)0.7434 (6)0.5012 (2)0.0186 (7)
H90.30510.61290.49680.022*
C100.2080 (5)0.8120 (6)0.5675 (2)0.0190 (8)
C110.1753 (5)1.0041 (6)0.5751 (2)0.0207 (8)
H110.12391.05080.62020.025*
C120.2191 (5)1.1265 (6)0.5156 (2)0.0229 (8)
H120.19861.25740.52070.028*
C130.2922 (5)1.0588 (6)0.4492 (2)0.0213 (8)
H130.32251.14330.40930.026*
C140.1800 (5)0.6713 (6)0.6309 (2)0.0199 (8)
C150.0029 (5)0.6049 (6)0.7415 (2)0.0185 (8)
C160.0253 (5)0.4121 (6)0.7483 (2)0.0217 (8)
H160.08050.34630.70850.026*
C170.0274 (5)0.3165 (6)0.8134 (2)0.0217 (8)
H170.00670.18500.81810.026*
C180.1096 (5)0.4096 (6)0.8715 (2)0.0218 (8)
C190.1431 (6)0.6016 (6)0.8636 (2)0.0249 (9)
H190.20380.66590.90210.030*
C200.0880 (5)0.6982 (6)0.7997 (2)0.0236 (9)
H200.10820.82970.79540.028*
C210.1360 (6)0.1300 (7)0.9478 (3)0.0312 (10)
H21A0.18340.08820.99670.047*
H21B0.20010.06230.90150.047*
H21C0.00310.10450.95240.047*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
O10.0561 (19)0.0329 (18)0.0277 (15)0.0003 (16)0.0204 (14)0.0033 (15)
O20.0502 (18)0.0226 (18)0.0357 (17)0.0006 (14)0.0189 (14)0.0045 (14)
O30.0308 (14)0.0276 (16)0.0280 (14)0.0096 (14)0.0108 (11)0.0054 (13)
O40.0270 (13)0.0223 (15)0.0321 (14)0.0074 (12)0.0132 (11)0.0065 (13)
O50.0359 (15)0.0235 (16)0.0254 (14)0.0018 (13)0.0099 (11)0.0038 (13)
N10.0271 (16)0.0230 (19)0.0244 (17)0.0037 (14)0.0065 (13)0.0036 (15)
N20.0203 (14)0.0194 (17)0.0210 (14)0.0040 (12)0.0087 (11)0.0000 (13)
N30.0208 (14)0.0169 (16)0.0221 (15)0.0033 (13)0.0043 (11)0.0014 (13)
C10.0181 (16)0.023 (2)0.0190 (17)0.0018 (15)0.0037 (13)0.0007 (16)
C20.0188 (16)0.0200 (19)0.0216 (17)0.0012 (15)0.0027 (13)0.0014 (16)
C30.0216 (17)0.021 (2)0.0215 (18)0.0018 (15)0.0030 (14)0.0031 (16)
C40.0231 (17)0.027 (2)0.0251 (18)0.0018 (16)0.0046 (14)0.0064 (18)
C50.026 (2)0.019 (2)0.034 (2)0.0037 (16)0.0035 (16)0.0049 (17)
C60.0236 (18)0.017 (2)0.0263 (19)0.0004 (15)0.0021 (14)0.0023 (17)
C70.0186 (16)0.023 (2)0.0218 (17)0.0017 (16)0.0039 (13)0.0038 (16)
C80.0151 (16)0.021 (2)0.0202 (17)0.0026 (14)0.0022 (13)0.0001 (16)
C90.0188 (15)0.0165 (19)0.0213 (18)0.0012 (14)0.0053 (13)0.0019 (16)
C100.0156 (15)0.0189 (19)0.0227 (18)0.0002 (15)0.0030 (13)0.0011 (17)
C110.0197 (16)0.021 (2)0.0227 (17)0.0001 (16)0.0061 (13)0.0013 (17)
C120.0227 (17)0.0156 (19)0.030 (2)0.0000 (15)0.0027 (15)0.0003 (17)
C130.0207 (16)0.019 (2)0.0239 (18)0.0027 (15)0.0038 (14)0.0058 (16)
C140.0181 (16)0.0194 (19)0.0219 (18)0.0013 (15)0.0018 (13)0.0022 (16)
C150.0164 (15)0.020 (2)0.0189 (17)0.0005 (14)0.0023 (13)0.0014 (16)
C160.0226 (18)0.019 (2)0.0244 (19)0.0015 (16)0.0065 (15)0.0033 (17)
C170.0225 (17)0.0146 (19)0.0282 (19)0.0001 (15)0.0045 (14)0.0008 (17)
C180.0202 (17)0.024 (2)0.0211 (17)0.0045 (15)0.0015 (14)0.0017 (17)
C190.0290 (19)0.024 (2)0.0235 (18)0.0011 (16)0.0090 (15)0.0035 (17)
C200.0258 (18)0.021 (2)0.0245 (19)0.0027 (16)0.0061 (15)0.0013 (17)
C210.031 (2)0.030 (2)0.033 (2)0.0023 (19)0.0060 (17)0.012 (2)
Geometric parameters (Å, º) top
O1—N11.235 (5)C8—C91.394 (5)
O2—N11.216 (5)C8—C131.401 (6)
O3—C71.221 (5)C9—C101.390 (5)
O4—C141.229 (5)C9—H90.9500
O5—C181.372 (5)C10—C111.398 (6)
O5—C211.425 (5)C10—C141.498 (5)
N1—C31.465 (5)C11—C121.396 (6)
N2—C71.346 (5)C11—H110.9500
N2—C81.425 (5)C12—C131.388 (5)
N2—H2N0.8800C12—H120.9500
N3—C141.359 (5)C13—H130.9500
N3—C151.424 (5)C15—C161.391 (5)
N3—H3N0.8800C15—C201.396 (5)
C1—C21.388 (6)C16—C171.388 (6)
C1—C61.389 (6)C16—H160.9500
C1—C71.511 (5)C17—C181.383 (6)
C2—C31.389 (5)C17—H170.9500
C2—H20.9500C18—C191.392 (6)
C3—C41.383 (6)C19—C201.380 (6)
C4—C51.376 (6)C19—H190.9500
C4—H40.9500C20—H200.9500
C5—C61.389 (6)C21—H21A0.9800
C5—H50.9500C21—H21B0.9800
C6—H60.9500C21—H21C0.9800
C18—O5—C21117.5 (3)C9—C10—C14116.1 (4)
O2—N1—O1122.6 (4)C11—C10—C14123.2 (4)
O2—N1—C3119.7 (3)C12—C11—C10119.2 (4)
O1—N1—C3117.7 (4)C12—C11—H11120.4
C7—N2—C8124.3 (3)C10—C11—H11120.4
C7—N2—H2N117.8C13—C12—C11120.6 (4)
C8—N2—H2N117.8C13—C12—H12119.7
C14—N3—C15125.8 (3)C11—C12—H12119.7
C14—N3—H3N117.1C12—C13—C8119.9 (4)
C15—N3—H3N117.1C12—C13—H13120.0
C2—C1—C6120.1 (4)C8—C13—H13120.0
C2—C1—C7123.0 (4)O4—C14—N3123.0 (4)
C6—C1—C7116.7 (4)O4—C14—C10121.4 (3)
C1—C2—C3117.3 (4)N3—C14—C10115.5 (4)
C1—C2—H2121.3C16—C15—C20119.2 (4)
C3—C2—H2121.3C16—C15—N3123.4 (4)
C4—C3—C2123.4 (4)C20—C15—N3117.4 (3)
C4—C3—N1118.6 (4)C17—C16—C15119.7 (4)
C2—C3—N1117.9 (4)C17—C16—H16120.2
C5—C4—C3118.2 (4)C15—C16—H16120.2
C5—C4—H4120.9C18—C17—C16121.0 (4)
C3—C4—H4120.9C18—C17—H17119.5
C4—C5—C6120.0 (4)C16—C17—H17119.5
C4—C5—H5120.0O5—C18—C17124.9 (4)
C6—C5—H5120.0O5—C18—C19115.6 (4)
C5—C6—C1120.9 (4)C17—C18—C19119.4 (4)
C5—C6—H6119.5C20—C19—C18119.9 (4)
C1—C6—H6119.5C20—C19—H19120.0
O3—C7—N2124.7 (4)C18—C19—H19120.0
O3—C7—C1120.0 (4)C19—C20—C15120.8 (4)
N2—C7—C1115.2 (3)C19—C20—H20119.6
C9—C8—C13119.7 (3)C15—C20—H20119.6
C9—C8—N2121.8 (4)O5—C21—H21A109.5
C13—C8—N2118.4 (4)O5—C21—H21B109.5
C10—C9—C8120.1 (4)H21A—C21—H21B109.5
C10—C9—H9119.9O5—C21—H21C109.5
C8—C9—H9119.9H21A—C21—H21C109.5
C9—C10—C11120.5 (4)H21B—C21—H21C109.5
C6—C1—C2—C31.6 (5)C9—C10—C11—C120.6 (5)
C7—C1—C2—C3173.7 (3)C14—C10—C11—C12175.0 (3)
C1—C2—C3—C42.2 (5)C10—C11—C12—C130.7 (6)
C1—C2—C3—N1175.9 (3)C11—C12—C13—C80.5 (6)
O2—N1—C3—C4177.1 (4)C9—C8—C13—C122.0 (6)
O1—N1—C3—C43.1 (5)N2—C8—C13—C12179.2 (3)
O2—N1—C3—C24.7 (5)C15—N3—C14—O40.2 (6)
O1—N1—C3—C2175.2 (3)C15—N3—C14—C10178.0 (3)
C2—C3—C4—C50.0 (6)C9—C10—C14—O428.3 (5)
N1—C3—C4—C5178.1 (3)C11—C10—C14—O4147.5 (4)
C3—C4—C5—C62.8 (6)C9—C10—C14—N3153.8 (3)
C4—C5—C6—C13.3 (6)C11—C10—C14—N330.4 (5)
C2—C1—C6—C51.1 (6)C14—N3—C15—C1626.6 (6)
C7—C1—C6—C5176.7 (3)C14—N3—C15—C20155.5 (4)
C8—N2—C7—O31.3 (6)C20—C15—C16—C171.4 (6)
C8—N2—C7—C1178.4 (3)N3—C15—C16—C17179.3 (3)
C2—C1—C7—O3142.4 (4)C15—C16—C17—C180.7 (6)
C6—C1—C7—O333.1 (5)C21—O5—C18—C171.8 (6)
C2—C1—C7—N237.9 (5)C21—O5—C18—C19180.0 (4)
C6—C1—C7—N2146.6 (3)C16—C17—C18—O5179.4 (3)
C7—N2—C8—C936.2 (5)C16—C17—C18—C191.3 (6)
C7—N2—C8—C13146.6 (4)O5—C18—C19—C20179.3 (3)
C13—C8—C9—C102.1 (5)C17—C18—C19—C202.4 (6)
N2—C8—C9—C10179.3 (3)C18—C19—C20—C151.7 (6)
C8—C9—C10—C110.9 (5)C16—C15—C20—C190.3 (6)
C8—C9—C10—C14176.8 (3)N3—C15—C20—C19178.3 (4)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N2—H2N···O4i0.882.092.908 (4)155
N3—H3N···O3ii0.882.213.056 (4)163
C5—H5···O2iii0.952.283.093 (5)143
C19—H19···O1iv0.952.443.365 (5)164
C21—H21C···O1v0.982.643.490 (5)145
Symmetry codes: (i) x+1, y+1/2, z+1; (ii) x, y+1/2, z+1; (iii) x, y1, z; (iv) x1, y, z+1; (v) x+1, y1/2, z+1.
Molecular coupling calculations (kcal mol-1) for the active hfXa site, the title compound, and the Apixaban molecule top
CompoundsBond energyaNo. of hydrogen bondsbHydrogen-bonding interaction residuesbvan der Waals interaction residuesb
(I)-7.71Gly218Trp215, Cys191, Ser195, Gln192, Cys220, Gly218, Ala190, Gly216, Gly 226, Asp189, Val213, Phe174, Glu217, Glu 146
Apixabanc-10.73Gly216, Gln192, Glu146Cys220, Tyr99, Glu97, Phe174, Thr98, Val213, Trp215, Gly226, Cys191, Asp189, Ser195, Ile227, Ala190, Gly218, Arg143
Notes: (a) The binding energy indicates the affinity and binding capacity for the active site of the enzyme protein fXa; (b) The number of hydrogen bonds and all amino acid residues involved in the enzyme-inhibitor complex were determined using AutoDock 4.2.6 (Trott & Olson, 2010); (c)The Apixaban molecule was used as a positive control ligand for the active site.
Equivalent poses of compound (I) in the active hfXa site, as a result of molecular coupling calculations (kcal mol-1) top
CompoundsBond energyaNo. of hydrogen bondsbHydrogen-bonding interaction residuesbvan der Waals interaction residuesb
(I) (pose 1)-7.71Gly218Trp215, Cys191, Ser195, Gln192, Cys220, Gly218, Ala190, Gly216, Gly 226, Asp189, Val213, Phe174, Glu217, Glu 146
(I) (pose 2)-7.61Gly192Phe174, Tyr99, Val213, Gly226, Trp215, Ser195, Asp189, Ala190, Gly218, Gly216, Cys191, Gln192, Ile 227, Lys96
(I) (pose 3)-7.42Gly 216, Gln192Cys220, Glu217, Phe174, Val213, Gly226, Cys191, Ser195, Ala190, Trp215, Gly218, Ile227
Notes: (a) The binding energy indicates the affinity and binding capacity for the active site of the enzyme protein fXa; (b) The number of hydrogen bonds and all amino acid residues involved in the enzyme-inhibitor complex were determined using AutoDock 4.2.6 (Trott & Olson, 2010); (c)The Apixaban molecule was used as a positive control ligand for the active site.
 

Funding information

RMF is grateful to Universidad del Valle and Banco de la República Colombia for the support received for the realization of the CI 1169 project.

References

First citationAgilent (2014). CrysAlis PRO. Agilent Technologies Ltd, Yarnton, England.  Google Scholar
First citationAgnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E. & Weitz, J. I. (2013). N. Engl. J. Med. 368, 699–708.  CrossRef CAS PubMed Google Scholar
First citationAllen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1–S19.  CrossRef Web of Science Google Scholar
First citationAltomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C., Polidori, G. & Camalli, M. (1994). J. Appl. Cryst. 27, 435.  CrossRef Web of Science IUCr Journals Google Scholar
First citationEtter, M. C. (1990). Acc. Chem. Res. 23, 120–126.  CrossRef CAS Web of Science Google Scholar
First citationFarrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationFrisch, M. J., et al. (2009). GAUSSIAN09. Gaussian Inc., Wallingford, CT, USA.  Google Scholar
First citationGroom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179.  Web of Science CrossRef IUCr Journals Google Scholar
First citationHathwar, V. R., Sist, M., Jørgensen, M. R. V., Mamakhel, A. H., Wang, X., Hoffmann, C. M., Sugimoto, K., Overgaard, J. & Iversen, B. B. (2015). IUCrJ, 2, 563–574.  Web of Science CSD CrossRef CAS PubMed IUCr Journals Google Scholar
First citationHirata, Y., Sasaki, T., Kanki, H., Choong, C.-J., Nishiyama, K., Kubo, G., Hotei, A., Taniguchi, M. & Mochizuki, H. (2018). Sci. Rep. 8, 1400, 1–9.  Google Scholar
First citationLahm, G. P., Selby, T. P., Freudenberger, J. H., Stevenson, T. M., Myers, B. J., Seburyamo, G., Smith, B. K., Flexner, L., Clark, C. E. & Cordova, C. (2005). Bioorg. Med. Chem. Lett. 15, 4898–4906.  CrossRef PubMed CAS Google Scholar
First citationLahm, G. P., Stevenson, T. M., Selby, T. P., Freudenberger, J. H., Cordova, D., Flexner, L., Bellin, C. A., Dubas, C. M., Smith, B. K., Hughes, K. A., Hollingshaus, J. G., Clark, C. E. & Benner, E. A. (2007). Bioorg. Med. Chem. Lett. 17, 6274–6279.  Web of Science CrossRef PubMed CAS Google Scholar
First citationLaskowski, R. & Swindells, M. (2011). J. Chem. Inf. Model. 51, 2778–2786.  CrossRef CAS PubMed Google Scholar
First citationLee, S., Lee, W., Nguyen, T., Um, I., Bae, J. & Ma, E. (2017). Int. J. Mol. Sci. 18, 1144–1170.  CrossRef Google Scholar
First citationLiu, J., Sun, C., Ma, W., Lu, Y.-J., Yu, L., Zhang, K. & Zeng, H. (2014). RSC Adv. 4, 54469–54473.  CSD CrossRef CAS Google Scholar
First citationLu, T. & Chen, F. (2012). J. Mol. Graphics Modell. 38, 314–323.  CrossRef Google Scholar
First citationMacrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst. 53, 226–235.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationParsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationPinto, D., Orwat, M., Koch, S., Rossi, K., Alexander, R., Smallwood, A., Wong, P., Rendina, A., Luettgen, J., Knabb, R., He, K., Xin, B., Wexler, R. R. & Lam, P. Y. S. (2007). J. Med. Chem. 50, 5339–5356.  CrossRef PubMed CAS Google Scholar
First citationPrasad, L. G., Krishnakumar, V., Nagalakshmi, R. & Manohar, S. (2011). Mater. Chem. Phys. 128, 90–95.  CrossRef CAS Google Scholar
First citationRacagni, G., Canonico, P. L., Ravizza, L., Pani, L. & AMoRe, M. (2004). Neuropsychobiology, 50, 134–143.  CrossRef PubMed CAS Google Scholar
First citationRigsby, R. & Parker, A. (2016). Biochem. Mol. Biol. Educ. 44, 433–437.  CrossRef CAS PubMed Google Scholar
First citationSheldrick, G. M. (2015). Acta Cryst. C71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
First citationSpackman, M. A. & Jayatilaka, D. (2009). CrystEngComm, 11, 19–32.  Web of Science CrossRef CAS Google Scholar
First citationTohnishi, M., Nakao, H., Furuya, T., Seo, A., Kodama, H., Tsubata, K., Fujioka, S., Kodama, H., Hirooka, T. & Nishimatsu, T. (2005). J. Pestic. Sci. 30, 354–360.  CrossRef CAS Google Scholar
First citationTrott, O. & Olson, A. (2010). J. Comput. Chem. 31, 455–461.  PubMed CAS Google Scholar
First citationTurner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Spackman, P. R., Jayatilaka, D. & Spackman, M. A. (2017). CrystalExplorer17. The University of Western Australia. https://https://crystalexplorer. scb. uwa. edu. au/.  Google Scholar
First citationXing, J., Yang, L., Zhou, J. & Zhang, H. (2018). Bioorg. Med. Chem. 26, 5987–5999.  CrossRef CAS PubMed Google Scholar
First citationYan, Y., Qin, B., Ren, C., Chen, X., Yip, Y. K., Ye, R., Zhang, D., Su, H. & Zeng, H. (2010). J. Am. Chem. Soc. 132, 5869–5879.  CSD CrossRef CAS PubMed Google Scholar
First citationYi, H.-P., Wu, J., Ding, K.-L., Jiang, X.-K. & Li, Z.-T. (2007). J. Org. Chem. 72, 870–877.  Web of Science CSD CrossRef PubMed CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds